V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10324946 | 10056304 | 1.62 | 72 | Palliative (P) | 2022-05-05 | 2022-05-05 | CABOZANTINIB | 02 | N | CETUXIMAB | 100488722 |
| 10325027 | 10056306 | 1.76 | 63 | Curative (C) | 2022-03-17 | 2022-03-24 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 100512860 |
| 10325047 | 10056307 | null | 86.8 | null | 2015-09-26 | 2017-07-17 | CETUXIMAB | 02 | null | ACALABRUTINIB | 101591204 |
| 10325053 | 10056308 | 1.8 | 73.1 | 03 | 2019-07-31 | 2019-08-05 | Acalabrutinib | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101399069 |
| 10325055 | 10056309 | 1.72 | 78 | 03 | null | 2018-05-08 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 101299208 |
| 10325217 | 10056310 | 1.65 | 69.4 | null | 2018-10-31 | 2018-11-01 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101008832 |
| 10325335 | 10056311 | 1.4 | 90 | Palliative (P) | 2018-06-17 | 2018-09-08 | Azacitidine | 02 | N | AZACITIDINE | 100154863 |
| 10325362 | 10056312 | 1.75 | 82 | 03 | 2021-03-18 | 2021-03-25 | Niraparib | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101732062 |
| 10325469 | 10056314 | 1.72 | 57.1 | Curative (C) | 2019-03-06 | 2019-03-07 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | CABOZANTINIB | 100944291 |
| 10325518 | 10056315 | 0 | 54.5 | Palliative (P) | 2019-03-13 | 2019-03-20 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | DABRAFENIB | 101583686 |
| 10325540 | 10056316 | 1.78 | 62 | null | 2019-09-21 | 2019-09-24 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 100900869 |
| 10325644 | 10056317 | 1.51 | 87.7 | null | 2021-01-28 | 2021-05-19 | Acalabrutinib | 02 | null | ACALABRUTINIB | 101855688 |
| 10325724 | 10056318 | null | 77 | Palliative (P) | 2019-12-29 | 2020-01-04 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | VINORELBINE | 101519240 |
| 10325922 | 10056319 | 1.79 | 66 | 03 | 2019-10-09 | 2020-03-31 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 100559810 |
| 10326145 | 10056321 | 1.63 | 58.4 | null | 2020-01-06 | 2020-01-06 | Bortezomib + Panobinostat | null | null | BORTEZOMIB + PANOBINOSTAT | 100592486 |
| 10326151 | 10056322 | 1.78 | 68.25 | null | 2018-02-04 | 2018-02-18 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 100266228 |
| 10326340 | 10056324 | 1.85 | 60.4 | Palliative (P) | 2022-03-27 | 2022-04-02 | Vinorelbine (oral) | 02 | N | ACALABRUTINIB | 100362469 |
| 10326468 | 10056326 | 1.83 | 106.6 | Palliative (P) | 2022-03-24 | 2022-03-28 | Azacitidine | 02 | N | AZACITIDINE | 100307281 |
| 10326531 | 10056327 | 1.8 | null | null | 2018-05-04 | 2018-07-14 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 100506387 |
| 10326810 | 10056328 | 1.63 | 93 | null | 2017-08-05 | 2017-08-12 | GEMCITABINE | 02 | null | GEMCITABINE | 100209077 |
| 10326909 | 10056330 | 1.53 | 93.1 | null | 2018-04-18 | 2018-07-11 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 100048468 |
| 10327041 | 10056331 | 1.61 | 69.5 | 03 | 2019-08-18 | 2019-08-28 | Vinorelbine (oral) | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101044919 |
| 10327208 | 10056334 | 1.72 | 46 | 02 | 2022-01-09 | 2022-01-22 | Chlorambucil | 02 | N | CHLORAMBUCIL | 100731818 |
| 10327469 | 10056336 | 1.7 | 83.6 | Palliative (P) | 2017-05-14 | 2017-05-14 | Chlorambucil | 02 | N | CHLORAMBUCIL | 100314293 |
| 10327521 | 10056337 | null | 76.4 | null | 2020-03-15 | 2021-09-05 | Acalabrutinib | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100946076 |
| 10327584 | 10056338 | 1.73 | 64.8 | null | 2019-01-11 | 2020-04-28 | Vinorelbine (oral) | 02 | null | CISPLATIN + GEMCITABINE | 100080710 |
| 10327623 | 10056339 | 1.82 | 78 | null | 2020-05-01 | 2020-10-28 | BORTEZOMIB + THALIDOMIDE | 99 | null | BUSULFAN | 101859539 |
| 10327625 | 10056340 | 1.75 | 93.5 | null | 2017-04-04 | 2017-04-04 | CVP R | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100216747 |
| 10327773 | 10056342 | 1.68 | 87.7 | Adjuvant (A) | 2016-09-14 | 2016-09-21 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 101226190 |
| 10327797 | 10056343 | 1.71 | 73.55 | Palliative (P) | 2018-09-12 | 2019-06-14 | Cyclophosphamide oral | N | N | CYCLOPHOSPHAMIDE | 100309726 |
| 10327843 | 10056344 | 1.58 | 99 | Palliative (P) | 2021-09-27 | 2021-11-25 | Chlorambucil | 2 | N | CHLORAMBUCIL | 100922357 |
| 10327900 | 10056345 | 1.8 | 51 | null | 2020-01-22 | 2020-02-01 | Bortezomib + Cyclophos + Dex | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100729197 |
| 10327920 | 10056346 | 1.59 | null | null | 2021-11-20 | 2021-11-28 | Chlorambucil | 02 | null | CHLORAMBUCIL | 101454638 |
| 10328154 | 10056350 | 1.58 | 75.4 | null | 2017-05-22 | 2017-06-19 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 100504596 |
| 10328293 | 10056353 | 1.74 | 71.6 | Adjuvant (A) | 2017-12-06 | 2017-12-22 | CABOZANTINIB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100552816 |
| 10328328 | 10056356 | 1.72 | 78.5 | Palliative (P) | 2019-04-20 | 2019-04-27 | GDP | 02 | N | CABOZANTINIB | 100134591 |
| 10328332 | 10056357 | 0 | 83 | Adjuvant (A) | 2018-01-12 | 2018-03-23 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 100986131 |
| 10328406 | 10056359 | 1.68 | 84.6 | null | 2020-06-03 | 2020-06-07 | MELPHALAN | 02 | null | MELPHALAN | 101538234 |
| 10328707 | 10056362 | 1.64 | 71.4 | Palliative (P) | 2020-07-28 | 2020-08-04 | CABOZANTINIB | 02 | N | BUSULFAN | 101501481 |
| 10328776 | 10056363 | 1.68 | 72.1 | null | 2015-03-29 | 2018-02-16 | Vinorelbine (oral) | 02 | null | ACALABRUTINIB | 101580898 |
| 10328926 | 10056365 | 1.71 | 72.4 | null | 2019-04-13 | 2019-04-14 | DABRAFENIB | null | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100824891 |
| 10328964 | 10056366 | 1.75 | 56.5 | Palliative (P) | 2019-01-22 | 2019-01-23 | null | 02 | N | BUSULFAN | 100653050 |
| 10329035 | 10056367 | 1.64 | 97 | Palliative (P) | 2019-11-13 | 2019-11-16 | CTD Attenuated (Thalidomide 50mg) | 02 | N | CAPECITABINE + IRINOTECAN | 100904689 |
| 10329175 | 10056369 | 1.81 | 88.8 | Palliative (P) | 2019-03-14 | 2020-01-04 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 100524645 |
| 10329420 | 10056371 | 1.67 | 0 | null | 2019-07-04 | 2019-07-11 | Palbociclib | 02 | null | PALBOCICLIB | 100516711 |
| 10329477 | 10056372 | 1.56 | 70.3 | null | 2021-06-23 | 2021-06-24 | Cisplatin | 02 | null | NIRAPARIB | 100717850 |
| 10329728 | 10056373 | null | 87.3 | Palliative (P) | 2021-12-12 | 2022-01-22 | IPILIMUMAB + NIVOLUMAB | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101767960 |
| 10329739 | 10056375 | null | 79.7 | 03 | 2021-05-03 | 2021-05-05 | Carboplatin + Liposomal Doxorubicin | 02 | N | NIRAPARIB | 100954058 |
| 10329756 | 10056376 | 1.64 | 78 | Curative (C) | 2020-05-15 | 2020-05-15 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 101160073 |
| 10330067 | 10056378 | 1.63 | 71 | Palliative (P) | 2016-03-22 | 2016-03-27 | Cabazitaxel | 02 | N | CABAZITAXEL | 101592767 |